Cargando...

Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences

BACKGROUND: Indacaterol is a novel, once-daily, inhaled, long-acting b2-agonist for patients with chronic obstructive pulmonary disease (COPD). The study objective was to evaluate the efficacy of indacaterol on quality of life and pulmonary function in patients with COPD in a real-world setting, and...

Descrición completa

Gardado en:
Detalles Bibliográficos
Formato: Artigo
Idioma:en
Publicado: Dove Medical Press 2014
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3904808/
https://ncbi.nlm.nih.gov/pubmed/24489464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S56777
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!